Confirm Antiphospholipid Syndrome with Antiphospholipid Antibodies (Option D)
Order a complete antiphospholipid antibody panel including lupus anticoagulant (LA), anticardiolipin antibodies (aCL) IgG and IgM, and anti-β2 glycoprotein I antibodies (aβ2GPI) IgG and IgM to confirm the diagnosis of antiphospholipid syndrome. 1
Why This Specific Panel
Since your patient already has one positive "anticoagulant" test (likely referring to lupus anticoagulant or anticardiolipin), you need the complete triad to properly diagnose APS. The 2025 ISTH guidance explicitly recommends concurrent testing for all three antibody groups 1:
- Lupus anticoagulant (LA) - measured via 3-step coagulation methodology using both APTT and dRVVT
- Anticardiolipin antibodies (aCL) - IgG and IgM isotypes
- Anti-β2 glycoprotein I antibodies (aβ2GPI) - IgG and IgM isotypes
Critical Timing Requirements
You must repeat the positive test at least 12 weeks apart to rule out transient antibody positivity, which does not qualify for APS diagnosis 1, 2. In the repeat testing, the same antibody that was initially positive must remain positive.
Why the Other Options Are Wrong
- Anti-CCP (Option A): This tests for rheumatoid arthritis, completely irrelevant to recurrent abortion
- Anti-dsDNA (Option B): This tests for systemic lupus erythematosus, not diagnostic for APS (though SLE can coexist with APS)
Risk Stratification Based on Antibody Profile
The antibody profile matters significantly for risk assessment 1:
- Triple positive (LA + aCL + aβ2GPI): Highest risk, strongest diagnostic confidence
- Double positive (aCL and aβ2GPI with concordant isotype): Moderate-high risk
- Single positive: Lower risk, but IgG isotype is more clinically relevant than IgM alone
- Persistent medium/high titer (>99th percentile): Critical for diagnosis
Laboratory Interpretation Pitfalls
Be aware that LA testing can be affected by anticoagulant therapy 2. If your patient is on:
- DOACs: Consider DOAC removal procedures before testing, or use Taipan snake venom time/Ecarin time
- Warfarin (VKA): LA testing requires careful interpretation; alternative assays may be needed
The solid-phase assays (aCL and aβ2GPI) are not affected by anticoagulation and should be interpreted according to local cutoff values 1.